Studies confirm proof-of-principle for Geron's Human Embryonic Stem Cell (HESC) derived hepatocytes

23-Apr-2007 - Geron Corporation announced that it has developed standardized hepatocytes from human embryonic stem cells (hESCs) that can model human hepatic drug metabolism. Published in Cloning and Stem Cells (Vol. 9, No. 1, 51-62), a paper written by Geron's scientific collaborators at the Roslin Institute ...

GTC Biotherapeutics obtains license to nuclear transfer patents

12-Apr-2007 - GTC Biotherapeutics, Inc. announced that it has been granted a non-exclusive worldwide license from Start Licensing, Inc., a joint venture between Geron Corporation and Exeter Life Sciences, Inc., for the patents and patent applications developed by the Roslin Institute to apply nuclear transfer ...

Viragen Reports Avian Transgenic Breakthrough: OVA(TM) System Expresses Interferon-Beta

23-Jan-2006 - Viragen, Inc. announced that the Company's scientists, along with its collaborators at the Roslin Institute and Oxford BioMedica plc, have successfully achieved expression of significant quantities of the human protein, interferon beta-1a, in the whites of eggs laid by transgenic hens using the ...

Lower-cost manufacturing for the production of many protein drugs by altering hens' genetic make-up

Roslin Institute in Cancer Breakthrough

20-Jul-2005 - Scientists at Edinburgh's Roslin Institute have made a breakthrough in their battle to create designer eggs which may help to produce drugs to fight cancer. By altering hens' genetic make-up, the team has caused the synthesis in egg white of a complex protein that may prove effective in treating ...

Viragen Reports Achievement of Key Avian Transgenics Milestone

Anti-Cancer Antibody Expressed In Chicken Eggs Promises to Revolutionize Drug Production

07-Jun-2005 - Viragen, Inc., Roslin Institute (Scotland) and Oxford BioMedica PLC jointly announced a dramatic breakthrough in their pioneering project to develop Avian Transgenic Biomanufacturing with the report of a functional humanized antibody protein incorporated in the whites of eggs laid by a transgenic ...

Viragen Reports Advancement in Avian Transgenics Biomanufacturing

Anti-cancer Antibody Expressed in Rooster

21-Feb-2005 - Viragen, Inc. announced an advancement in its program to develop avian transgenic biomanufacturing for the purpose of using chickens as bioreactors for the efficient and economical production of human pharmaceutical protein-based drugs in their eggs. Viragen, in collaboration with Roslin ...